Calcitonin gene-related peptide Recruiting Phase 4 Trials for Migraine Other

IndicationsStatusPurposePhase
RecruitingOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT04592952Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab